New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive worsening at 78 weeks with ...
A well-known antiviral drug commonly prescribed for herpes infections may be doing more harm than good in people with early Alzheimer’s disease, according to a new clinical trial. Rather than slowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results